“
TL;DR
This is a narrative review summarizing recent preclinical research on plant-derived natural products, highlighting their diverse antioxidant, antimicrobial, anti-inflammatory, and neuroprotective activities in vitro and in animal models.
Life · 2 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This is a narrative review summarizing recent preclinical research on plant-derived natural products, highlighting their diverse antioxidant, antimicrobial, anti-inflammatory, and neuroprotective activities in vitro and in animal models.
This narrative review summarizes findings from multiple in vitro and in vivo animal studies on plant-derived natural products. The reviewed studies employed various experimental designs, including analyses of chemical compositions and antioxidant capacity, in silico docking simulations, and models of obesity, inflammation, stroke, and carcinogenesis in rats and mice. Central results include the demonstration of antioxidant, antimicrobial, anti-inflammatory, neuroprotective, and anticancer activities from different plant extracts and compounds. The review also discusses literature evaluations of specific compounds like plagiochilins and mogrol, noting promising but preliminary evidence. Key limitations highlighted include the preclinical nature of the evidence, small sample sizes in the few noted human trials, and gaps in understanding exact molecular mechanisms, optimal dosages, and safety profiles. The implications are that these natural products show potential for pharmaceutical, nutraceutical, and dermocosmetic development, but further rigorous research, including clinical trials, is needed.